H-LEU-ARG-PRO-OH
|
|
|
- CAS号:
- 133943-59-6
- 英文名:
- H-LEU-ARG-PRO-OH
- 英文别名:
- LRP;HPTPalpha;Leu-Arg-Pro;R-PTP-alpha;H-LEU-ARG-PRO-OH;LHRH 7-9 SEQUENCE;Leucylarginylproline;H-LEU-ARG-PRO-OH 2HCL;LHRH (7-9) SEQUENCE 2HCL;L-Proline,L-leucyl-L-arginyl-
- 中文名:
- H-LEU-ARG-PRO-OH
- 中文别名:
- 肺耐药相关蛋白重组兔单抗;L-亮氨酰-L-精氨酰-L-脯氨酸;PTPRA 多克隆抗体-E-AB-52203;化合物LEUCYLARGINYLPROLINE;化合物LEUCYLARGINYLPROLINE,10 MM DMSO 溶液
- CBNumber:
- CB5260122
- 分子式:
- C17H32N6O4
- 分子量:
- 384.47
- MOL File:
- 133943-59-6.mol
|
|
|
H-LEU-ARG-PRO-OH化学性质
-
密度:
-
1.39±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
-15°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
-
酸度系数(pKa):
-
3.39±0.20(Predicted)
-
|
H-LEU-ARG-PRO-OH性质、用途与生产工艺
Leucylarginylproline是血管紧张素转换酶 (ACE) 抑制剂，IC50值为0.27μM。
Intravenous injection of Leucylarginylproline (30mg/kg) causes a decrease in the blood pressure. The maximum mean blood pressure reduction (about 15 mmHg) occurrs about 2 min after the injection. Leucylarginylproline peptide reduces the blood pressure by about 15 mmHg at the fourth hour and shows a maximal reduction effect of about 35 mmHg at the eighth hour after oral administration.
H-LEU-ARG-PRO-OH
上下游产品信息
上游原料
下游产品
133943-59-6, H-LEU-ARG-PRO-OH 相关搜索:
- 抑制剂
- 试剂盒-Elisa试剂盒
- C17H32N6O4
- PTPRA 多克隆抗体-E-AB-52203
- 肺耐药相关蛋白重组兔单抗
- 化合物LEUCYLARGINYLPROLINE,10 MM DMSO 溶液
- 化合物LEUCYLARGINYLPROLINE
- L-亮氨酰-L-精氨酰-L-脯氨酸
- 133943-59-6
- R-PTP-alpha
- HPTPalpha
- Leucylarginylproline, 10 mM in DMSO
- Angiotensin-converting Enzyme (ACE),Inhibitor,inhibit,Leucylarginylproline
- L-Proline,L-leucyl-L-arginyl-
- Leucylarginylproline
- LRP
- Leu-Arg-Pro
- LHRH 7-9 SEQUENCE
- H-LEU-ARG-PRO-OH 2HCL
- H-LEU-ARG-PRO-OH
- LHRH (7-9) SEQUENCE 2HCL